(Q40876662)

English

The osteoblast-specific transcription factor Cbfa1 contributes to the expression of osteoprotegerin, a potent inhibitor of osteoclast differentiation and function

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

24 September 2017

The osteoblast-specific transcription factor Cbfa1 contributes to the expression of osteoprotegerin, a potent inhibitor of osteoclast differentiation and function (English)

1 reference

Europe PubMed Central

PubMed publication ID

24 September 2017

0 references

author name string

Thirunavukkarasu K

1

1 reference

Europe PubMed Central

PubMed publication ID

24 September 2017

Halladay DL

2

1 reference

Europe PubMed Central

PubMed publication ID

24 September 2017

Miles RR

3

1 reference

Europe PubMed Central

PubMed publication ID

24 September 2017

Yang X

4

1 reference

Europe PubMed Central

PubMed publication ID

24 September 2017

Galvin RJ

5

1 reference

Europe PubMed Central

PubMed publication ID

24 September 2017

Chandrasekhar S

6

1 reference

Europe PubMed Central

PubMed publication ID

24 September 2017

Martin TJ

7

1 reference

Europe PubMed Central

PubMed publication ID

24 September 2017

Onyia JE

8

1 reference

Europe PubMed Central

PubMed publication ID

24 September 2017

language of work or name

0 references

publication date

1 August 2000

1 reference

Europe PubMed Central

PubMed publication ID

24 September 2017

number of pages

10

1 reference

based on heuristic

inferred from page(s)

Journal of Biological Chemistry

1 reference

Europe PubMed Central

PubMed publication ID

24 September 2017

275

1 reference

Europe PubMed Central

PubMed publication ID

24 September 2017

33

1 reference

Europe PubMed Central

PubMed publication ID

24 September 2017

25163-25172

1 reference

Europe PubMed Central

PubMed publication ID

24 September 2017

Osf2/Cbfa1: a transcriptional activator of osteoblast differentiation

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M000322200

21 January 2018

Targeted disruption of Cbfa1 results in a complete lack of bone formation owing to maturational arrest of osteoblasts

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M000322200

21 January 2018

Cbfa1, a candidate gene for cleidocranial dysplasia syndrome, is essential for osteoblast differentiation and bone development

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M000322200

21 January 2018

Collagenase 3 is a target of Cbfa1, a transcription factor of the runt gene family involved in bone formation

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M000322200

21 January 2018

Both AP-1 and Cbfa1-like factors are required for the induction of interstitial collagenase by parathyroid hormone

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M000322200

21 January 2018

Transcriptional regulation of osteopontin gene in vivo by PEBP2alphaA/CBFA1 and ETS1 in the skeletal tissues

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M000322200

21 January 2018

Missense mutations abolishing DNA binding of the osteoblast-specific transcription factor OSF2/CBFA1 in cleidocranial dysplasia.

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M000322200

21 January 2018

Mutations involving the transcription factor CBFA1 cause cleidocranial dysplasia

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M000322200

21 January 2018

Gamma-ray-induced dominant mutations that cause skeletal abnormalities in mice. II. Description of proved mutations

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M000322200

21 January 2018

Animal model: skeletal anomalies in mice with cleidocranial dysplasia.

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M000322200

21 January 2018

Role of osteoblasts in hormonal control of bone resorption—A hypothesis

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M000322200

21 January 2018

Modulation of osteoclast differentiation

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M000322200

21 January 2018

Modulation of osteoclast differentiation and function by the new members of the tumor necrosis factor receptor and ligand families

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M000322200

21 January 2018

Osteoprotegerin ligand is a cytokine that regulates osteoclast differentiation and activation

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M000322200

21 January 2018

RANK is the essential signaling receptor for osteoclast differentiation factor in osteoclastogenesis

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M000322200

21 January 2018

Osteoprotegerin: a novel secreted protein involved in the regulation of bone density

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M000322200

21 January 2018

Osteoclast differentiation factor is a ligand for osteoprotegerin/osteoclastogenesis-inhibitory factor and is identical to TRANCE/RANKL

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M000322200

21 January 2018

TRANCE is a novel ligand of the tumor necrosis factor receptor family that activates c-Jun N-terminal kinase in T cells

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M000322200

21 January 2018

A homologue of the TNF receptor and its ligand enhance T-cell growth and dendritic-cell function

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M000322200

21 January 2018

TRANCE (tumor necrosis factor [TNF]-related activation-induced cytokine), a new TNF family member predominantly expressed in T cells, is a dendritic cell-specific survival factor

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M000322200

21 January 2018

osteoprotegerin-deficient mice develop early onset osteoporosis and arterial calcification

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M000322200

21 January 2018

Osteoclastogenesis inhibitory factor (OCIF) directly inhibits bone-resorbing activity of isolated mature osteoclasts.

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M000322200

21 January 2018

Severe osteoporosis in mice lacking osteoclastogenesis inhibitory factor/osteoprotegerin

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M000322200

21 January 2018

Cloning and characterization of the gene encoding human osteoprotegerin/osteoclastogenesis-inhibitory factor

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M000322200

21 January 2018

Two domains unique to osteoblast-specific transcription factor Osf2/Cbfa1 contribute to its transactivation function and its inability to heterodimerize with Cbfbeta

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M000322200

21 January 2018

SV40-transformed simian cells support the replication of early SV40 mutants

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M000322200

21 January 2018

A pitfall of using a second plasmid to determine transfection efficiency

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M000322200

21 January 2018

Parathyroid hormone regulates the rat collagenase-3 promoter in osteoblastic cells through the cooperative interaction of the activator protein-1 site and the runt domain binding sequence

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M000322200

21 January 2018

Rapid detection of octamer binding proteins with 'mini-extracts', prepared from a small number of cells

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M000322200

21 January 2018

Two distinct osteoblast-specific cis-acting elements control expression of a mouse osteocalcin gene

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M000322200

21 January 2018

Identification of AML-1 and the (8;21) translocation protein (AML-1/ETO) as sequence-specific DNA-binding proteins: the runt homology domain is required for DNA binding and protein-protein interactions

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M000322200

21 January 2018

Calcitonin responsiveness and receptor expression in porcine and murine osteoclasts: a comparative study

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M000322200

21 January 2018

A conserved cysteine residue in the runt homology domain of AML1 is required for the DNA binding ability and the transforming activity on fibroblasts

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M000322200

21 January 2018

An AML-1 consensus sequence binds an osteoblast-specific complex and transcriptionally activates the osteocalcin gene

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M000322200

21 January 2018

Runt homology domain proteins in osteoblast differentiation: AML3/CBFA1 is a major component of a bone-specific complex

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M000322200

21 January 2018

The tissue-specific nuclear matrix protein, NMP-2, is a member of the AML/CBF/PEBP2/runt domain transcription factor family: interactions with the osteocalcin gene promoter

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M000322200

21 January 2018

Reciprocal gene expression of osteoclastogenesis inhibitory factor and osteoclast differentiation factor regulates osteoclast formation

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M000322200

21 January 2018

Identifiers

10.1074/JBC.M000322200

1 reference

Europe PubMed Central

PubMed publication ID

24 September 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

24 September 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q40876662&oldid=1909416598"